Study details
Enrolling now
Safety and Feasibility of Intranasal Insulin in Patients With Spinal Cord Injury
HealthPartners Institute
NCT IDNCT07384052ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1
Ages
18–84
Locations
1 site in MN
What this study is about
This Phase 1 study is testing Regular Insulin in people with spinal cord injury. The primary outcome being measured is Safety measured by number of serious adverse events (SAE) and adverse events (AE).
Simplified from trial records by PatientMatch.
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Injection / IV
How treatment is administered
Treatment Assignment
Standard assignment
Assignment is predetermined by the study protocol.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug routes
injection
Endpoints
Primary: Safety measured by number of serious adverse events (SAE) and adverse events (AE)
Body systems
Neurology